A Message From Myriad About COVID-19
In light of the public health preparedness efforts currently underway, Myriad's top priorities are protecting the health and safety of employees, our customers, and their patients. Click here to learn more about our streamlined testing options that will keep you and your patients safe.

Every Man Deserves A Better Answer

Prolaris is an in-depth assessment of a patient’s prostate cancer aggressiveness. It is the only test that measures how fast a prostate cancer tumor is growing.

Hereditary Cancer & You

Does cancer run in your family? Find out if you may be a candidate for hereditary cancer testing.

“It Had Affected My Family As Much As It Had Affected Just Me.”

A patient’s prostate cancer journey with genetic and genomic testing

For Physicians

Prolaris results leads to changes in management in at least half of patients.

For Patients

Every individual’s prostate cancer is different, the results of your Prolaris test are unique to you.

The Prolaris Impact

How Prolaris has shaped patients’ lives

Avoid unnecessary treatments that bring unwanted side effects, costs, and trauma to your family.

9 out of 10 patients pay $0
average out of pocket cost
Clinically validated in all risk groups
clinical validation studies
more predictive than PSA and Gleason alone

Step 1

Tissue Sampling

Prostate tissue sample from biopsy will be sent to Myriad.

Step 2

Testing & Analysis

The tissue is tested and analyzed to determine the aggressiveness of the prostate cancer in question.

Step 3

Discuss Results

Once the sample(s) have been processed, the results are sent directly to the physician. The results will contain a personalized Prolaris Score, as well as the risk of dying from the prostate cancer or having the cancer spread outside the prostate within the next ten years.

How Can We Help Direct You?

Depending on your situation, we’d like to ensure we show you the most relevant information possible.